Upon successful completion, the ASSIST platform aspires to function as an important technology enabler for cervical cancer research by allowing any medical group active in this area to use its facilities and/or contribute their own results. Therefore, ASSIST will address the need of large sample sizes and will help to promote collaborative international biomedical research in the area of cervical cancer.

ASSIST will enable the cervical cancer medical researcher to use various HPV data, environmental, lifestyle and medical history items from diverse medical records, with minimal effort and cost. The investigation of associations among all these factors and genetic data will identify risk factors that can then be used at the point of care by gynecologists to identify women, who are at high risk of developing cervical cancer.

Consequently, low-risk women can avoid costly and potentially morbid diagnostic and therapeutic procedures while high-risk women will receive appropriate treatment.